Page last updated: 2024-08-25

rosiglitazone and Hyperhomocysteinemia

rosiglitazone has been researched along with Hyperhomocysteinemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amiri, F; Ebrahimian, T; Iglarz, M; Javeshgani, D; LemariƩ, CA; Paradis, P; Savoia, C; Schiffrin, EL1
Kaur, T; Pal Singh, A; Singh Bedi, PM; Singh, N; SinghDahiya, R1
Jaggi, AS; Sain, H; Sharma, B; Singh, N1
Hayden, MR1

Other Studies

4 other study(ies) available for rosiglitazone and Hyperhomocysteinemia

ArticleYear
Countervailing vascular effects of rosiglitazone in high cardiovascular risk mice: role of oxidative stress and PRMT-1.
    Clinical science (London, England : 1979), 2010, Feb-09, Volume: 118, Issue:9

    Topics: Animals; Carotid Artery, Internal; Cholesterol; Cholesterol, Dietary; Disease Models, Animal; Drug Evaluation, Preclinical; Endothelium, Vascular; Female; Hyperhomocysteinemia; Methylenetetrahydrofolate Reductase (NADPH2); Mice; Mice, Knockout; Nitrites; Oxidative Stress; Protein-Arginine N-Methyltransferases; Rosiglitazone; Superoxides; Thiazolidinediones

2010
Ameliorative role of rosiglitazone in hyperhomocysteinemia-induced experimental cardiac hypertrophy.
    Journal of cardiovascular pharmacology, 2010, Volume: 56, Issue:1

    Topics: Animals; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrosis; Homocysteine; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Male; Methionine; Oxidative Stress; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones

2010
Pharmacological investigations on potential of peroxisome proliferator-activated receptor-gamma agonists in hyperhomocysteinemia-induced vascular dementia in rats.
    Neuroscience, 2011, Sep-29, Volume: 192

    Topics: Animals; Dementia, Vascular; Disease Models, Animal; Hyperhomocysteinemia; Hypoglycemic Agents; Male; Maze Learning; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones

2011
Homocysteine competes for the peroxisome proliferator-activated receptor nuclear receptors.
    Journal of the cardiometabolic syndrome, 2008,Winter, Volume: 3, Issue:1

    Topics: Diabetes Mellitus, Type 2; Diet; Folic Acid; Humans; Hyperhomocysteinemia; Hypoglycemic Agents; Peroxisome Proliferator-Activated Receptors; Rosiglitazone; Thiazolidinediones

2008